Sarcoidosis Therapeutics Market to record USD 64.82 Mn growth | North American market to create...

Published on 26 Apr 2022 on WFMZ Eastern Pennsylvania and Western New Jersey

NEW YORK, April 26, 2022 /PRNewswire/ -- The "Sarcoidosis Therapeutics Market" report by Technavio...

Read the rest of the article

Start tracking your investments with Statfolio

Halozyme Therapeutics, Inc. HALO reported first-quarter 2022 adjusted earnings of 47 cents per sh...

Zacks via Yahoo Finance 11 May 2022

We expect investors to focus on the sales performance of Assertio Holdings’ ASRT marketed drugs w...

Zacks via Yahoo Finance 26 Apr 2022

NEW YORK, April 26, 2022 /PRNewswire/ -- The "Sarcoidosis Therapeutics Market" report by Technavi...

WFMZ Eastern Pennsylvania and Western New Jersey 26 Apr 2022

Elon Musk, leaning on Skadden, Arps, Slate, Meagher & Flom for legal advice, struck a deal on Mon...

Law.com 26 Apr 2022

In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts. Y...

Insider Monkey via Yahoo Finance 20 Apr 2022

Antares Pharma Inc's (NASDAQ:ATRS) short percent of float has risen 8.8% since its last report. T...

Benzinga 14 Apr 2022

Halozyme Therapeutics HALO announced that it has entered into a definitive agreement with Antares...

Zacks via Yahoo Finance 14 Apr 2022

Antares Pharma ATRS shares ended the last trading session 49.2% higher at $5.58. The jump came on...

Zacks via Yahoo Finance 14 Apr 2022

Halozyme Therapeutics Inc (NASDAQ: HALO) will acquire Antares Pharma Inc (NASDAQ: ATRS) for $5.60...

Benzinga via Yahoo Finance 13 Apr 2022

Shares of Antares Pharma Inc. rocketed 46.3% in premarket trading Wednesday toward a two-decade h...

MarketWatch 13 Apr 2022